Company Overview

Vadivarhe Speciality Chemicals Limited (VSCL) was incorporated on February 23, 2009. Prior to its incorporation, the company's precursor, Fem Care Pharma Ltd, was promoted by Mr. Sunil Haripant Pophale. In 2009, Dabur India Limited acquired Fem Care Pharma Ltd. Subsequently, as per the terms of a Division Transfer Agreement dated May 07, 2009, the Specialty Chemical Division of Fem Care Pharma Limited was transferred to Vadivarhe Speciality Chemicals Limited as a going concern. Following this transfer, the company has continued to operate its Specialty Chemical division under the leadership of the Promoter, Mr. Sunil Haripant Pophale. The company is based in Nashik, Maharashtra, with its registered office located at Gat No 204 Vadivarhe Igatpu, Igatpuri, Maharashtra, 422403.

Financial Performance and Market Position

Vadivarhe Speciality Chemicals Ltd operates in the Basic Materials / Specialty Chemicals sector. Over the last 5 years, the company's revenue has grown at a yearly rate of 5.71%, which is lower than the industry average of 11.08%. Market share has decreased from 0.05% to 0.04% over the same period, indicating challenges in maintaining competitive positioning within the rapidly growing specialty chemicals sector.

The company's market capitalization was ₹38.3 Cr as of August 1, 2025. The stock has experienced significant volatility, with a 52-week high of ₹75.45 and a 52-week low of ₹21.05.

Despite its established manufacturing capabilities and export presence, the company has faced financial difficulties. VSCL's net profit fell by -350% year-on-year to ₹-2.70 Cr in Q4 FY2021-2022. The company exhibits a low return on equity of -59.8% over the last 3 years. Audited FY25 results were approved, with the auditor flagging going concern doubts and accumulated losses. New internal and secretarial auditors have been appointed.

Key Financial Metrics

- Market Capitalization: ₹38.3 Cr (as of 01/08/2025)

- Promoter Holding: 66.8%

- Revenue (2023): ₹40.1 Cr

- P/E Ratio: 76.92 (as of 01/08/2025)

- Recent Return (3 Years): 12.43%

- Recent Profitability (Q4 FY2021-2022): ₹-2.70 Cr (Net Profit)

- Return on Equity (3 Years): -59.8%

Business Operations and Production Capacity

Vadivarhe Speciality Chemicals Limited is an India-based company engaged in the manufacturing of organic chemicals, inorganic chemicals, bio-chemicals, bulk drugs, drug intermediates, and active pharmaceutical ingredients (APIs), along with related services. The company's product range includes intermediates, ingredients for personal and hair care products, and specialty chemicals for API manufacturers. The company commenced API manufacturing in 2010.

The company operates a cGMP production facility in Nashik, Maharashtra, with an installed capacity of 150 MTPA, geared towards producing high-quality intermediate products. Raw materials are sourced primarily from the local market and also imported from China. Finished products are sold both domestically and exported to countries including the UK, USA, Switzerland, and Malaysia.

Product Portfolio

The company's diverse product portfolio spans multiple categories:

- Intermediates: Trimethyl ortho propionate, Tributyl ortho propionate, Trimethyl ortho valerate, Trimethyl ortho butyrate, Triethyl ortho benzoate, Trimethyl ortho benzoate, Tributyl ortho valerate, 4-Aminomorpholine, and 1-Bromo-4-tert butyl benzene.

- Personal Care Ingredients: Sodium thioglycolate (Powder) and Calcium thioglycolate (Powder).

- Specialty Chemicals: Tert-Butoxy-bis (dimethyl amino) methane and 3-Aminophthalhydrazide sodium salt.

Management and Leadership

Mr. Sunil H Pophale serves as the Chairman of the company, leading it since its inception. Mr. Manoj Kumar holds the position of Company Secretary. Promoter Holding stands at 66.8%, indicating strong promoter commitment to the business.

Recent Corporate Developments

The company has experienced recent changes in its management structure.

- June 9, 2025: Whole-time Director Anil Suryavanshi resigned due to personal reasons, effective June 9, 2025.

- September 30, 2024: The 15th Annual General Meeting (AGM) of the company was scheduled to be held on this date.

Investment Considerations

Vadivarhe Speciality Chemicals Ltd presents a mixed investment profile. While it operates within the growing specialty chemicals sector, possesses established manufacturing capabilities, and has an export presence, it faces significant financial challenges. These include accumulated losses and auditor-flagged going concern issues. The stock exhibits high volatility, with substantial price swings between its 52-week high and low, reflecting investor uncertainty regarding the company's future prospects. Potential investors are advised to carefully evaluate the company's financial health and turnaround prospects before making investment decisions.